Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
Authors
Keywords
Cannabidiol, Alzheimer’s disease, Long-term potentiation, PPARγ, Beta amyloid peptide, 5HT<sub>1A</sub>, Adenosine A<sub>2A</sub>, CB<sub>1</sub>R
Journal
NEUROCHEMICAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-03-24
DOI
10.1007/s11064-018-2513-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
- (2017) Eva Martínez-Pinilla et al. Frontiers in Pharmacology
- Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
- (2015) R B Laprairie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synaptic mechanisms of adenosine A2Areceptor-mediated hyperexcitability in the hippocampus
- (2014) Diogo M. Rombo et al. HIPPOCAMPUS
- Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice
- (2014) David Cheng et al. PSYCHOPHARMACOLOGY
- Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
- (2013) Vanessa Kappel da Silva et al. MOLECULAR NEUROBIOLOGY
- Synaptic plasticity in health and disease: introduction and overview
- (2013) T. V. P. Bliss et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity
- (2013) Andrew J. Nicoll et al. Nature Communications
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
- (2012) Alison Ribeiro et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The therapeutic potential of the endocannabinoid system for Alzheimer's disease
- (2012) Tim Karl et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
- (2011) George W. Booz FREE RADICAL BIOLOGY AND MEDICINE
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Aβ1–42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
- (2011) Jihoon Jo et al. NATURE NEUROSCIENCE
- Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
- (2011) Giuseppe Esposito et al. PLoS One
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- (2011) Elen V. Fagherazzi et al. PSYCHOPHARMACOLOGY
- Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites
- (2011) Darragh B. Freir et al. Nature Communications
- The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
- (2010) Jessica M. Mc Donald et al. BRAIN
- Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways
- (2010) CJ Ledgerwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- Control of Cannabinoid CB1 Receptor Function on Glutamate Axon Terminals by Endogenous Adenosine Acting at A1 Receptors
- (2010) A. F. Hoffman et al. JOURNAL OF NEUROSCIENCE
- 5-HT1Areceptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
- (2009) Leonardo B.M. Resstel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Time-dependent vascular actions of cannabidiol in the rat aorta
- (2009) Saoirse E. O'Sullivan et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
- (2009) D. Ryan et al. JOURNAL OF NEUROSCIENCE
- Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
- (2009) Juha Laurén et al. NATURE
- The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic–ischemic brain damage in mice is mediated by CB2 and adenosine receptors
- (2009) A. Castillo et al. NEUROBIOLOGY OF DISEASE
- Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
- (2008) Alline Cristina Campos et al. PSYCHOPHARMACOLOGY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
- (2007) J M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started